BioSpace News Archive

Biotech Bay

New Publication Reinforces Clinical Utility of Afirma Genomic Sequencing Classifier in Thyroid Cancer Diagnosis

Veracyte, Inc. (Nasdaq: VCYT) announced today the publication of new long-term clinical utility data showing that the company’s Afirma Genomic Sequencing Classifier (GSC) helped reduce unnecessary surgeries in patients with indeterminate thyroid nodule cytology

November 3, 2021
·
6 min read
Genetown

Homology Medicines to Participate in Upcoming Investor Conferences - Nov 03, 2021

Homology Medicines, Inc., a clinical-stage genetic medicines company, announced participation in the following virtual conferences:

November 3, 2021
·
1 min read
Deals

Bright Minds Biosciences Commences Trading on the Nasdaq Under the Ticker Symbol “DRUG”

Bright Minds Biosciences today announced that The Nasdaq Stock Market LLC has approved the listing of the Company’s common stock on The Nasdaq Capital Market (“Nasdaq”).

November 3, 2021
·
6 min read
Genetown

Stoke Therapeutics to Present at Upcoming Investor Conferences on November 10

Stoke Therapeutics, Inc. today announced that management will present at two upcoming investor conferences in November.

November 3, 2021
·
2 min read
Drug Development

Database Lock Completed for Innovation Pharmaceuticals’ Phase 2 Clinical Trial of Brilacidin for COVID-19

Innovation Pharmaceuticals today announced that the Company has received confirmation that hard lock of the database was completed for its Phase 2 clinical trial of Brilacidin for treatment of moderate-to-severe COVID-19 in hospitalized patients (see NCT04784897 ).

November 3, 2021
·
3 min read
FDA

Rapid Medical to Initiate the First-Ever Trial to Expand Stroke Treatment to Distal Regions of the Brain–Offering Thrombectomy Treatment to New Patient Population

Rapid Medical today announced FDA investigational device exemption (IDE) approval for the first-ever trial to expand interventional stroke treatment to distal regions of the brain.

November 3, 2021
·
3 min read
FDA

TransThera Receives Fast Track Designation from FDA for its Core Product TT-00420 to Treat Cholangiocarcinoma

TransThera Sciences announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to its phase II stage product TT-00420 for the treatment of patients with Cholangiocarcinoma (CCA) who have no standard treatment options.

November 3, 2021
·
3 min read
Biotech Beach

Sorrento Receives Brazilian Health Regulatory Agency (ANVISA) Approval for COVISTIX™ (COVID-19 Virus Antigen Detection Test) for Brazil

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced receipt of approval from the Brazilian regulatory agency (ANVISA) for COVISTIX in Brazil.

November 3, 2021
·
6 min read
Business

Halomine, Inc. Announces the Appointment of Dr. Xeuhong Ren as Chief Scientific Officer, Three New Board Members

Halomine™, Inc. announced today the appointment of Dr. Xeuhong Ren as Chief Scientific Officer as well as 3 new members to their Board of Directors; Andy Gilicinski, Michael Aberman, and Alden Zecha.

November 3, 2021
·
3 min read
Defence Therapeutics Reports Successful Completion of Its COVID-19 Vaccine AccuVAC-PT001 Toxicology Studies in Rabbits

The AccuVAC-PT001 vaccine is an injectable vaccine capable of inducing a powerful and sustainable antibody response in both rodent and non-rodent models.

November 3, 2021
·
4 min read